GLP1R and type 2 diabetes mellitus: However, infusion of exendin‐(9–39), a GLP‐1R antagonist,45 resulted in a slight deterioration of postprandial plasma glucose in RYGB subjects, suggesting that the resolution of T2D after RYGB may be explained by mechanisms other than enhanced GLP‐1 action.46